Enrique A Conterno Fibrogen Inc (FGEN) insider trading activity

Enrique A Conterno is Chief Executive Officer of FIBROGEN INC. Currently has a direct ownership of 374,722 shares of FGEN, which is worth approximately $258,558. The most recent transaction as insider was on Jul 07, 2023, when has been sold 1,880 shares (Common Stock) at a price of $2.8 per share, resulting in proceeds of $5,264. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 375K

0% 3M change

0.5% 12M change

Total Value Held $258,558

Enrique A Conterno Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 07 2023	SELL Open market or private sale	$5,264 $2.8 p/Share	1,880 Reduced 0.5%	374,722 Common Stock
Jun 07 2023	SELL Open market or private sale	$151,604 $17.04 p/Share	8,897 Reduced 2.31%	376,602 Common Stock
Apr 10 2023	SELL Open market or private sale	$36,482 $19.52 p/Share	1,869 Reduced 0.49%	382,999 Common Stock
Mar 10 2023	SELL Open market or private sale	$638,097 $20.2 p/Share	31,589 Reduced 7.59%	384,868 Common Stock
Mar 08 2023	SELL Open market or private sale	$522,059 $21.16 p/Share	24,672 Reduced 6.48%	356,111 Common Stock
Mar 08 2023	BUY Grant, award, or other acquisition	-	60,349 Added 12.66%	416,460 Common Stock
Feb 21 2023	BUY Grant, award, or other acquisition	-	85,300 Added 18.3%	380,783 Common Stock

Jan 06 2023	SELL Open market or private sale	$30,683 $19.95 p/Share	1,538 Reduced 0.52%	295,483 Common Stock
Dec 08 2022	SELL Open market or private sale	$40,153 $15.79 p/Share	2,543 Reduced 0.85%	297,020 Common Stock
Oct 06 2022	SELL Payment of exercise price or tax liability	$18,481 $14.26 p/Share	1,296 Reduced 0.43%	299,563 Common Stock
Sep 06 2022	SELL Payment of exercise price or tax liability	$21,725 $12.26 p/Share	1,772 Reduced 0.59%	300,859 Common Stock
Jul 06 2022	SELL Payment of exercise price or tax liability	$16,070 $12.4 p/Share	1,296 Reduced 0.43%	302,631 Common Stock
Jun 06 2022	SELL Payment of exercise price or tax liability	$16,834 $9.5 p/Share	1,772 Reduced 0.58%	301,940 Common Stock
Apr 07 2022	SELL Payment of exercise price or tax liability	$16,689 $12.73 p/Share	1,311 Reduced 0.43%	303,712 Common Stock
Mar 07 2022	SELL Payment of exercise price or tax liability	$89,858 $12.69 p/Share	7,081 Reduced 2.27%	305,023 Common Stock
Feb 14 2022	BUY Grant, award, or other acquisition	-	179,400 Added 36.5%	312,104 Common Stock
Jan 06 2022	SELL Payment of exercise price or tax liability	$21,396 $13.93 p/Share	1,536 Reduced 1.14%	132,704 Common Stock
Oct 06 2021	SELL Payment of exercise price or tax liability	$18,962 $10.2 p/Share	1,859 Reduced 1.37%	134,239 Common Stock
Jul 06 2021	SELL Payment of exercise price or tax liability	$46,587 $25.06 p/Share	1,859 Reduced 1.35%	136,098 Common Stock
Feb 24 2021	BUY Grant, award, or other acquisition	-	82,000 Added 37.4%	137,273 Common Stock
Jan 06 2021	SELL Payment of exercise price or tax liability	$207,295 $38.31 p/Share	5,411 Reduced 8.92%	55,273 Common Stock

Also insider at

LLY

ELI LILLY & Co Healthcare

SVP&Pres, LillyDiab & LillyUSA

EAC